Vanda gets nod to submit drug application that FDA previously refused

Washington Business Journal

May 13, 2020

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) has finally made progress in its squabble with regulators. The D.C. biotech announced Wednesday it can now resubmit its application to the…